Induction of microRNA-214-5p in human and rodent liver fibrosis

Fibrogenesis and Tissue Repair

Volumn 5, Issue 1, 2012, Pages

  Iizuka, Masashi ^a,c   Ogawa, Tomohiro ^a,b,c   Enomoto, Masaru ^a,c   Motoyama, Hiroyuki ^a,c   Yoshizato, Katsutoshi ^a,c   Ikeda, Kazuo ^a,c   Kawada, Norifumi ^a,c  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KINKI UNIVERSITY   (Japan)

^c PhoenixBio USA Corporation   (Japan)

Author keywords

Collagen; Hepatocyte; Non coding RNA; Stellate cell; Transforming growth factor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; GELATINASE A; GELATINASE B; MICRORNA 214; MICRORNA 214 5P; TRANSCRIPTION FACTOR TWIST; TRANSCRIPTION FACTOR TWIST1; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ALPHA SMOOTH MUSCLE ACTIN GENE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE; GENE FUNCTION; GENE INDUCTION; GENE OVEREXPRESSION; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL; LIVER FIBROSIS; MALE; MATRIX METALLOPROTEINASE 2 GENE; MATRIX METALLOPROTEINASE 9 GENE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; STELLATE CELL; TRANSFORMING GROWTH FACTOR BETA1 GENE; UPREGULATION;

EID: 84868584039     PISSN: None     EISSN: 17551536     Source Type: Journal    
DOI: 10.1186/1755-1536-5-12     Document Type: Article

References (39)

1. Friedman SL. Evolving challenges in hepatic fibrosis. Nat Rev Gastroenterol Hepatol 2010, 7:425-436. 10.1038/nrgastro.2010.97, 20585339.
2. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000, 275:2247-2250. 10.1074/jbc.275.4.2247, 10644669.
3. Kawada N. Evolution of hepatic fibrosis research. Hepatol Res 2011, 41:199-208. 10.1111/j.1872-034X.2011.00776.x, 21338451.
4. Bataller R, Brenner DA. Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liv Dis 2001, 21:437-451.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
6. Ambros V. The functions of animal microRNAs. Nature 2004, 16:350-355.
7. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007, 100:1579-1588. 10.1161/CIRCRESAHA.106.141986, 17478730.
8. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genomics 2007, 31:367-373. 10.1152/physiolgenomics.00144.2007, 17712037.
9. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007, 13:613-618. 10.1038/nm1582, 17468766.
10. Pandey P, Brors B, Srivastava PK, Bott A, Boehn SN, Groene HJ, Gretz N. Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 2008, 9:624. 10.1186/1471-2164-9-624, 2640396, 19102782.
11. Dillhoff M, Wojcik SE, Bloomston M. MicroRNAs in solid tumors. J Surg Res 2009, 154:349-354. 10.1016/j.jss.2008.02.046, 18656897.
12. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Puré E, Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210. 10.1038/ncb1681, 18193036.
13. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008, 105:10513-10518. 10.1073/pnas.0804549105, 2492472, 18663219.
14. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008, 18:997-1006. 10.1038/cr.2008.282, 18766170.
15. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005, 435:834-838. 10.1038/nature03702, 15944708.
16. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P. Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA. Science 2005, 309:1577-1581. 10.1126/science.1113329, 16141076.
17. Li YP, Gottwein JM, Scheel TK, Jensen TB, Bukh J. MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5′ UTR. Proc Natl Acad Sci U S A 2011, 108:4991-4996. 10.1073/pnas.1016606108, 3064388, 21383155.
18. Yamaura Y, Nakajima M, Takagi S, Fukami T, Tsuneyama K, Yokoi T. Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS One 2012, 7:e30250. 10.1371/journal.pone.0030250, 3281829, 22363424.
19. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun 2010, 391:316-321. 10.1016/j.bbrc.2009.11.056, 19913496.
20. Sekiya Y, Ogawa T, Yoshizato K, Ikeda K, Kawada N. Suppression of hepatic stellate cell activation by microRNA-29b. Biochem Biophys Res Commun 2011, 412:74-79. 10.1016/j.bbrc.2011.07.041, 21798245.
21. Lakner AM, Steuerwald NM, Walling TL, Ghosh S, Li T, McKillop IH, Russo MW, Bonkovsky HL, Schrum LW. Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 2012, 56:300-310.
22. Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB. Twist-1 regulates the miR-199a/214 cluster during development. Nucleic Acids Res 2009, 37:123-128. 10.1093/nar/gkn920, 2615617, 19029138.
23. Denby L, Ramdas V, McBride MW, Wang J, Robinson H, McClure J, Crawford W, Lu R, Hillyard DZ, Khanin R, Agami R, Dominiczak AF, Sharpe CC, Baker AH. miR-21 and miR-214 are consistently modulated during renal injury in rodent models. Am J Pathol 2011, 179:661-672. 10.1016/j.ajpath.2011.04.021, 3157202, 21704009.
24. van Mil A, Grundmann S, Goumans MJ, Lei Z, Oerlemans MI, Jaksani S, Doevendans PA, Sluijter JP. MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release. Cardiovasc Res 2012, 93:655-665. 10.1093/cvr/cvs003, 22227154.
25. Ogawa T, Enomoto M, Fujii H, Sekiya Y, Yoshizato K, Ikeda K, Kawada N. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 2012, Epub ahead of print.
26. Mu YP, Ogawa T, Kawada N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. Lab Invest 2010, 90:245-56. 10.1038/labinvest.2009.123, 19949375.
27. Derfoul A, Juan AH, Difilippantonio MJ, Palanisamy N, Ried T, Sartorelli V. Decreased microRNA-214 levels in breast cancer cells coincides with increased cell proliferation, invasion and accumulation of the Polycomb Ezh2 methyltransferase. Carcinogenesis 2011, 32:1607-1614. 10.1093/carcin/bgr184, 21828058.
28. Vaksman O, Stavnes HT, Kaern J, Trope CG, Davidson B, Reich R. miRNA profiling along tumour progression in ovarian carcinoma. J Cell Mol Med. 2011, 15:1593-1602. 10.1111/j.1582-4934.2010.01148.x, 20716115.
29. Penna E, Orso F, Cimino D, Tenaglia E, Lembo A, Quaglino E, Poliseno L, Haimovic A, Osella-Abate S, De Pittà C, Pinatel E, Stadler MB, Provero P, Bernengo MG, Osman I, Taverna D. microRNA-214 contributes to melanoma tumour progression through suppression of TFAP2C. EMBO J 2011, 30:1990-2007. 10.1038/emboj.2011.102, 3098476, 21468029.
30. Qiang R, Wang F, Shi LY, Liu M, Chen S, Wan HY, Li YX, Li X, Gao SY, Sun BC, Tang H. Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells. Int J Biochem Cell Biol 2011, 43:632-641. 10.1016/j.biocel.2011.01.002, 21216304.
31. Murakami Y, Toyoda H, Tanaka M, Kuroda M, Harada Y, Matsuda F, Tajima A, Kosaka N, Ochiya T, Shimotohno K. The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS One 2011, 6:e16081. 10.1371/journal.pone.0016081, 3025920, 21283674.
32. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C, Luedde T. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218. 10.1002/hep.23922, 20890893.
33. Venugopal SK, Jiang J, Kim TH, Li Y, Wang SS, Torok NJ, Wu J, Zern MA. Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am J Physiol Gastrointest Liver Physiol 2010, 298:G101-106. 10.1152/ajpgi.00220.2009, 2806096, 19892940.
34. Yang Z, Chen S, Luan X, Li Y, Liu M, Li X, Liu T, Tang H. MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of HeLa cells. IUBMB Life 2009, 61:1075-1082. 10.1002/iub.252, 19859982.
35. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ. MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Res 2008, 68:425-433. 10.1158/0008-5472.CAN-07-2488, 18199536.
36. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009, 36:61-74. 10.1016/j.molcel.2009.08.008, 2761245, 19818710.
37. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996, 24:289-293.
38. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005, 54:142-151. 10.1136/gut.2004.042127, 1774377, 15591520.
39. Kristensen DB, Kawada N, Imamura K, Miyamoto Y, Tateno C, Seki S, Kuroki T, Yoshizato K. Proteome analysis of rat hepatic stellate cells. Hepatology 2000, 32:268-277. 10.1053/jhep.2000.9322, 10915733.